• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, September 17, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Undescended testes in boyhood linked to testicular cancer and infertility in adulthood

Bioengineer by Bioengineer
August 29, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Led by the University of Sydney researchers and published today in The Lancet Child & Adolescent Health, this is the first population-based cohort study to assess both adult fertility and cancer risk after surgical correction (orchidopexy) for undescended testes in early childhood. The procedure moves an undescended testicle into the scrotum and permanently fixes it there.

"In addition to an increased risk of testicular cancer, we found that boys with undescended testes had decreased paternity and increased use of assisted reproductive technologies for infertility in later life," said the University of Sydney's Professor Natasha Nassar, the study's senior author.

"The study provides new evidence to support international guidelines recommending surgery before 18 months for boys with undescended testes to reduce the risk of both testicular cancer and infertility later in life."

But compliance with these guidelines remains poor with almost half of all boys with undescended testes in Australia and more than three-quarters worldwide being operated on after 18 months, say the research team from the University of Sydney, Curtin University and the Telethon Kids Institute.

"Before this study, there was no evidence-based information on the impact of early surgery on the future risk of testicular cancer and infertility in adult males," said study leader, Dr Francisco Schneuer of the University of Sydney.

"Early diagnosis, ongoing examination and monitoring by parents and health practitioners and timely referral to surgery of boys with undescended testes is important to ensure adherence with guidelines.

"Early surgery can reduce the risk of malignancy and male infertility, and ultimately has the potential to reduce future adult male reproductive disorders."

Study details

This is a population-based cohort study of 350,835 boys born in Western Australia between 1970 and 1999. The cohort was followed until 2016 by linking to data registries for hospital admissions, birth defects, cancer, and assisted reproductive technologies.

Key findings

    + Boys with undescended testes had 2.4 times the risk of adult testicular cancer compared to unaffected boys

    + The risk of testicular cancer increased by 6 percent with each 6-month increase in age at time of surgery (orchidopexy)

    + Boys with undescended testes had a 20 percent lower chance of paternity in adulthood compared to unaffected boys, and were more than twice as likely to use assisted reproductive technology for infertility as adults.

Male reproductive disorders increasing worldwide

    + Undescended testes is the most common reproductive birth defect in infant boys. One in 100 boys are affected and will require surgery

    + Testicular cancer affects young men aged 20-40 years, is the second most common cancer in young men and while rare, has increased by 50 percent in the last 30 years

    + Male infertility is a major challenge, with 5-10 percent of men worldwide being infertile.

###

Media Contact

Dan Gaffney
[email protected]
61-481-004-782
@SydneyUni_Media

http://www.usyd.edu.au/

Share12Tweet7Share2ShareShareShare1

Related Posts

Selective Presynaptic Inhibition Controls Fly Leg Proprioception

September 17, 2025

Innovative Implant Resets Blood Pressure Regulation Following Spinal Cord Injury

September 17, 2025

Researchers Uncover Four Key Immune Responses Triggered by COVID-19 Vaccines

September 17, 2025

Emerging Pathogens in Healthcare and Community Settings, Including Rising Sexually Transmitted Infections, Pose Serious Antimicrobial Resistance Threats

September 17, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    155 shares
    Share 62 Tweet 39
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    67 shares
    Share 27 Tweet 17
  • Scientists Achieve Ambient-Temperature Light-Induced Heterolytic Hydrogen Dissociation

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

‘Molecular Glue’ Activates Immune System to Combat Neuroblastoma

New Study Reveals Lower Melanoma Rates Among Individuals with Multiple Tattoos

A Motor-Sparing Local Anesthetic: Is It Within Reach?

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.